Evaluation of the effectiveness of artemether–lumefantrine and artesunate–pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial

The Lancet Microbe · Published 2026-06-01 · DOI 10.1016/j.lanmic.2025.101344

Free full text

Authors (36)

Migbaru Keffale Bezabih, Tadesse Misganaw, Legesse Alamerie Ejigu, Stefano Rosillo, Hiwot Teka, Dawit Hailu Alemayehu, Bethlehem Adnew, Bereket Hailegiorgis, Samuel Girma, Mekonnen Tadesse, Fikregabrail Aberra Kassa, Mikiyas Gebremichael, Desalegn Abeje Tefera, Wakweya Chali, Sinknesh Wolde Behaksera, Lina Alemayehu, Jimma Dinsa Deressa, Melat Abdo, Getnet Habtamu, Addisu Gizat, Woyneshet Gelaye Yalew, Tadesse Hailu, Molalegne Bitew, Peter Mumba, Mateusz M Plucinski, Samaly Souza, Dhruviben S Patel, Eldin Talundzic, Hiwot Solomon Taffese, Kebede Etana Geleta, Degu Mehari, Gudissa Assefa Bayissa, Teun Bousema, Jon Eric Tongren, Jimee Hwang, Fitsum G. Tadesse

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Bezabih, M., Misganaw, T., Ejigu, L., et al. (2026). Evaluation of the effectiveness of artemether–lumefantrine and artesunate–pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-group trial. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101344

Related articles